Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 326

The DOI matches its Crossref record; 316 of the 316 references it cites were found in a registry or an index.

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

Open access
Cunningham, Richard, Hansen, Carsten Gram·2022·Clinical Science

Abstract

Tumorigenesis is a highly complex process, involving many interrelated and cross-acting signalling pathways. One such pathway that has garnered much attention in the field of cancer research over the last decade is the Hippo signalling pathway. Consisting of two antagonistic modules, the pathway plays an integral role in both tumour suppressive and oncogenic processes, generally via regulation of a diverse set of genes involved in a range of biological functions. This review discusses the history of the pathway within the context of cancer and explores some of the most recent discoveries as to how this critical transducer of cellular signalling can influence cancer progression. A special focus is on the various recent efforts to therapeutically target the key effectors of the pathway in both preclinical and clinical settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/cs20201474

Cites

316 of 316 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 316 references

Research works printed but not linked: 12

  1. Evans, 2009, Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II], Genet. Med., 11, 599, 10.1097/GIM.0b013e3181ac9a27 · doi:10.1097/gim.0b013e3181ac9a27
  2. Begnami, 2007, Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization, Hum. Pathol., 38, 1345, 10.1016/j.humpath.2007.01.027 · doi:10.1016/j.humpath.2007.01.027
  3. Yakirevich, 2020, NF2 mutation-driven renal cell carcinomas (RCC): a comprehensive genomic profiling (CGP) study, J. Clin. Oncol., 38, 726, 10.1200/JCO.2020.38.6_suppl.726 · doi:10.1200/jco.2020.38.6_suppl.726
  4. Zhao, 2007, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control, Genes Dev., 21, 2747, 10.1101/gad.1602907 · DOI · Paper page
  5. Lee, 2016, Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements, Oncotarget, 7, 7480, 10.18632/oncotarget.7060 · doi:10.18632/oncotarget.7060
  6. Russell-Goldman, 2021, Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma, J. Cutan. Pathol., 48, 403, 10.1111/cup.13924 · doi:10.1111/cup.13924
  7. Nishimura, 2021, Cutaneous primary NUT carcinoma with BRD3-NUTM1 fusion, Am. J. Surg. Pathol., 45, 1582, 10.1097/PAS.0000000000001801 · doi:10.1097/pas.0000000000001801
  8. Pei, 2015, YAP is a critical oncogene in human cholangiocarcinoma, Oncotarget, 6, 17206, 10.18632/oncotarget.4043 · DOI
  9. Carter, 1994, Loss of heterozygosity at 11q22-q23 in breast cancer, Cancer Res., 54, 6270
  10. Messmer, 2001, Verteporfin for age-related macular degeneration, Ann. Pharmacother., 35, 1593, 10.1345/aph.10365 · doi:10.1345/aph.10365 · Paper page
  11. Taniguchi, 2015, A gp130-Src-YAP module links inflammation to epithelial regeneration, Nature, 519, 57, 10.1038/nature14228 · DOI · Paper page
  12. Whitehouse, 2005, Drugs to treat inflammation: a historical introduction, Curr. Med. Chem., 12, 2931, 10.2174/092986705774462879 · doi:10.2174/092986705774462879

Cited by

See all 326

Metadata

Authors
Cunningham, R., & Hansen, C. G.
Venue
Clinical Science
Published
2022-02
Volume
136
Issue
3
Pages
197-222
ISSN
  • 0143-5221 (ISSN-L)
  • 1470-8736
OpenAlex
W4210383344
Cited by
326
References
316
FWCI
29.02
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. https://app.cochat.ai/papers/10.1042/cs20201474
The paper
Cunningham, R., & Hansen, C. G. (2022). The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clinical Science. https://doi.org/10.1042/cs20201474

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.